Eyebright Medical Technology Financials

Market Capitalization CN¥13.18 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	34.09
Forward PE	25.06
Price to Sales TTM	CN¥9.05
Price to Book MRQ	CN¥5.28
Enterprise to Revenue	9.21
Enterprise to EBITDA	23.58

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	25.95%
Operating Margin	29.83%
Return on Assets TTM	8.11%
Return on Equity TTM	14.83%

Income Statement

Revenue TTM	CN¥1,456,801,920
Revenue per Share TTM	CN¥7.71
Quarterly Revenue Growth	15.10%
Gross Profit TTM	CN¥938,661,312
EBITDA	CN¥456,625,572
Net Income to Common TTM	CN¥378,057,664
Diluted EPS TTM	CN¥2.00
Quarterly Earnings Growth YoY	-10.10%

Balance Sheet

Total Cash MRQ	CN¥495,442,752
Total Cash per Share MRQ	CN¥2.61
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	23.89
Current Ratio MRQ	4.48
Book Value per Share MRQ	CN¥12.92

Cash Flow

Operating Cash Flow TTM	CN¥369,299,584
Levered Free Cash Flow TTM	CN¥-110,498,656

688050 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	189,544,528
Float Shares	129,005,901
Avg 10 Volume	2,485,434
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	34.49%
% Held by Institutions	22.58%

Stock Price Summary

Beta	0.48
Fifty Two Week Low	CN¥65.17
Fifty Two Week High	CN¥118.00
Fifty Two Week Change	1.43%
Day 50 MA	CN¥74.57
Day 200 MA	CN¥89.70

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.96
Forward Annual Dividend Yield	2.89%
Trailing Annual Dividend Rate	CN¥0.49
Trailing Annual Dividend Yield	0.72%
Payout Ratio	24.50%
Dividend Date
Ex Dividend Date	2024-06-05
Last Split Factor
Last Split Date	2024-06-05